
When you read this article entirely, it’s like what in the heck is this now? Seriously read the analytics that will be taking place and the...
When you read this article entirely, it’s like what in the heck is this now? Seriously read the analytics that will be taking place and the...
Here we go again, and advertising from the Pittsburgh newspaper has also been cut, but the article states that has gone on for a few years w...
What a week it has been so far as well as last week as well. It is worrisome as to what the American Public perceives today as a “real” val...
This is just taking this a little too far and we know when you let Quants go wild, they will go, and go and go and quantitate and create spu...
One thing I think that can safely be said is Andy Slavitt, a one time Goldman Sachs banker and United Healthcare Subsidiary CEO of Ingenix w...
For the independent pharmacy, generic drug costs have gone up as high as 30 percent and the pharmacy cannot price match big chain drug stor...
I talk a bit about stock buy backs, why? Because as a consumer or a patient, we pay for them. Insurance companies, all the majors on the S...
This is a republished blog post from March of 2014 and someone asked me to run it again, so here it is with a couple updates in the body and...
We all know how big business has to focus on stock buy backs, acquisitions, etc. today so donating perfectly good products that have been in...
I read one article and of course this is something that always occurs with new zoning and changing the landscape in the US, but darn there ...
If you are not aware of the Medicare Advantage Re-Run of the Risk Assessment model, I’ll give you a link where you can read up. At risk wou...